These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
635 related items for PubMed ID: 12387009
1. [Application and practice of intensive insulin therapy]. Kishikawa H, Soejima H, Tamama Y, Araki E, Shichiri M. Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009 [No Abstract] [Full Text] [Related]
2. [Multiple insulin injections therapy as an intensive insulin therapy]. Kishikawa H, Wake N, Shichiri M. Nihon Rinsho; 1997 Nov; 55 Suppl():249-54. PubMed ID: 9434476 [No Abstract] [Full Text] [Related]
3. [The effect of diabetic treatment on the development and progression of diabetic complications]. Nakai T. Nihon Rinsho; 1997 Nov; 55 Suppl():711-20. PubMed ID: 9434553 [No Abstract] [Full Text] [Related]
6. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1]. Jarosz-Chobot P. Wiad Lek; 2004 Nov; 57(5-6):263-6. PubMed ID: 15518073 [Abstract] [Full Text] [Related]
11. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy. Sahin SB, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C. Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389 [Abstract] [Full Text] [Related]
12. The importance of titrating starting insulin regimens in patients with type 2 diabetes. Garber AJ. Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():10-3. PubMed ID: 19817778 [No Abstract] [Full Text] [Related]
13. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Kanc K, Janssen MM, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ, Heine RJ. Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173 [Abstract] [Full Text] [Related]
14. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern. Currie CJ, Johnson JA. Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688 [Abstract] [Full Text] [Related]
17. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes. Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B, Urakami T, Battelino T, Hanas R, International Society for Pediatric and Adolescent Diabetes. Pediatr Diabetes; 2014 Sep; 15 Suppl 20():115-34. PubMed ID: 25182312 [No Abstract] [Full Text] [Related]
18. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment]. Mozdzan M, Ruxer J, Loba J. Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330 [Abstract] [Full Text] [Related]
19. [New methods in insulin treatment]. Neuwirth G. Orv Hetil; 2005 Jan 16; 146(3):111-6. PubMed ID: 15693442 [Abstract] [Full Text] [Related]
20. Role of subcutaneous insulin management protocols and order sets in inpatient diabetes management. Houlden RL, Moore S, Cornish W, Tiwana K. Can J Diabetes; 2014 Apr 16; 38(2):101-17. PubMed ID: 24690505 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]